Zhengbo Song

机构：Zhejiang Cancer Hospital

发表论文 20 篇 · 总被引 84 次 · h-index 5

代表论文

• D3S-001 in advanced solid tumors with KRASG12C mutations: a phase 1 trial (2025 · Nature Medicine · 被引 21)
• Preoperative elevation of serum C‐reactive protein as an indicator of poor prognosis for early‐stage esophageal squamous cell carcinoma (2013 · The Kaohsiung Journal of Medical Sciences · 被引 19)
• Erlotinib as a salvage treatment for patients with advanced non-small cell lung cancer after failure of gefitinib treatment. (2011 · PubMed · 被引 11)
• Third-line therapy for advanced non-small-cell lung cancer patients: feasible drugs for feasible patients (2010 · Medical Oncology · 被引 11)
• Efficacy and safety of glecirasib (JAB-21822) monotherapy and in combination with cetuximab in patients with KRAS G12C-mutated advanced colorectal cancer. (2025 · Journal of Clinical Oncology · 被引 9)
• International guidelines on the diagnosis and treatment of NUT carcinoma (2025 · The Innovation · 被引 5)